TrialFrontiers in public health2022

Cost-Effectiveness Analysis of a Three-Drug Regimen Containing Bevacizumab for the Treatment of Recurrent Pediatric

Zhaoyan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.